The Mubadala Investment Investment Company intends to invest in the Rodenstock Group, specialized in manufacturing medical lenses.
According to Arab Net, swap on a minority share as well as investment funds receive consultations from ABACK funds.
The deal is expected in mid-2021 after obtaining regulatory approvals.
Mubadala said in a statement on its website on Sunday that Rodnstock was founded in 1877 and remained more than 140 years at the forefront of medical manufacturing companies.
The company is characterized by a busy record in developing innovative and experienced technologies in the markets.
Camella Macapelli Languhawili, head of life science department in Swap: Rodnstock occupies the lead between the manufacturers of lenses manufacturing in the European market, and enjoys a prestigious reputation with excellent innovation capabilities.
Minna Hamoudi, a first vice president in the Life Science Department: will work in partnership with Abax to support the executive management team in Rodenstock to achieve its vision of growth through innovation, the implementation of trade and insignic plans, while continuing to provide the highest level of service to customers and partners.
The headquarters of Rodenstock is located in Munich and has about 4,900 people worldwide and has a network of subsidiaries and distribution partners in more than 85 countries.
